The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
EWS/FLI-1 is a chimeric protein formed by a tumor-specific 11;22 translocation found in both Ewing's sarcoma and primitive neuroectodermal tumor of childhood. EWS/FLI-1 has been shown to be a potent transforming gene, suggesting that it plays an important role in the genesis of these human tumors. We now demonstrate that EWS/FLI-1 has the characteristics of an aberrant transcription factor. Subcellular fractionation experiments localized the EWS/FLI-1 protein to the nucleus of primitive neuroectodermal tumor cells. EWS/FLI-1 specifically bound in vitro an ets-2 consensus sequence similarly to normal FLI-1. When coupled to a GAL4 DNA-binding domain, the amino-terminal EWS/FLI-1 region was a much more potent transcriptional activator than the corresponding amino-terminal domain of FLI-1. Finally, EWS/FLI-1 efficiently transformed NIH 3T3 cells, but FLI-1 did not. These data suggest that EWS/FLI-1, functioning as a transcription factor, leads to a phenotype dramatically different from that of cells expressing FLI-1. EWS/FLI-1 could disrupt normal growth and differentiation either by more efficiently activating FLI-1 target genes or by inappropriately modulating genes normally not responsive to FLI-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The strong transactivation activity in the N terminus of EWS contributes to the function of the resulting oncogenic fusion protein (185).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [185]
Citations
Cites
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907 · cited 3×
“This polypeptide fragment included EWS amino acid residues 244 to 264 (6) fused to residues 241 to 284 of FLI-1 (30).”
BackgroundMethodde Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
Crozat, A., Åman, P., Mandahl, N., & Ron, D. (1993) · Nature · doi:10.1038/363640a0 · Cited by 894
The Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842
Kamps, M. P., Murre, C., Sun, X.-H., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90658-2 · Cited by 697
Dalton, S., & Treisman, R. (1992) · Cell · doi:10.1016/0092-8674(92)90194-h · Cited by 672
Nourse, J., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S. D., & Cleary, M. L. (1990) · Cell · doi:10.1016/0092-8674(90)90657-z · Cited by 662
Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Stringer, K. F., Ingles, C. J., & Greenblatt, J. (1990) · Nature · doi:10.1038/345783a0 · Cited by 579
Cited by
A Developmental Switch in the Response of DRG Neurons to ETS Transcription Factor Signaling
Hippenmeyer, S., Vrieseling, E., Sigrist, M., Portmann, T., Laengle, C., Ladle, D. R., & Arber, S. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030159 · Cited by 1,088
Sorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747
Self-citationAnalyses of non-coding somatic drivers in 2,658 cancer whole genomes
Rheinbay, E., Nielsen, M. M., Abascal, F., Wala, J. A., Shapira, O., Tiao, G., Hornshøj, H., Hess, J. M., Juul, R. I., Lin, Z., et al. (2020) · Nature · doi:10.1038/s41586-020-1965-x · Cited by 602
Tirode, F., Surdez, D., Ma, X., Parker, M., Le Deley, M. C., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête-Lalami, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 565
The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
de Alava, E., Kawai, A., Healey, J. H., Fligman, I., Meyers, P. A., Huvos, A. G., Gerald, W. L., Jhanwar, S. C., Argani, P., Antonescu, C. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1248 · Cited by 524
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
Gerald, W. L., Ladanyi, M., de Alava, E., Cuatrecasas, M., Kushner, B. H., LaQuaglia, M. P., & Rosai, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3028 · Cited by 417
Molecular Biology of the Ewing’s Sarcoma/Primitive Neuroectodermal Tumor Family
de Alava, E., & Gerald, W. L. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.204 · Cited by 360
Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells
Riggi, N., Cironi, L., Provero, P., Suvà, M.-L., Kaloulis, K., Garcia-Echeverria, C., Hoffmann, F., Trumpp, A., & Stamenkovic, I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1696 · Cited by 359
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma
Smith, R., Owen, L. A., Trem, D. J., Wong, J. S., Whangbo, J. S., Golub, T. R., & Lessnick, S. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.004 · Cited by 351
Self-citationTLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling
Zinszner, H., Sok, J., Immanuel, D., Yin, Y., & Ron, D. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.15.1741 · Cited by 350
Biology of EWS/ETS fusions in Ewing's family tumors
Arvand, A., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204598 · Cited by 348
Self-citationFolpe, A. L., Hill, C. E., Parham, D. M., O'Shea, P. A., & Weiss, S. W. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200012000-00010 · Cited by 340
Zoubek, A., Dockhorn-Dworniczak, B., Delattre, O., Christiansen, H., Niggli, F., Gatterer-Menz, I., Smith, T. L., Jürgens, H., Gadner, H., & Kovar, H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1245 · Cited by 322
FUS/ERG gene fusions in Ewing's tumors.
Shing, D. C., McMullan, D. J., Roberts, P., Smith, K. K., Chin, S., Nicholson, J. C., Tillman, R. M., Ramani, P., Cullinane, C., & Coleman, N. (2003) · PubMed · Cited by 308
Folpe, A. L., Chand, E. M., Goldblum, J. R., & Weiss, S. W. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200108000-00011 · Cited by 306
Fredericks, W. J., Galili, N., Mukhopadhyay, S., Rovera, G., Bennicelli, J., Barr, F. G., & Rauscher, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1522 · Cited by 305
Gerald, W. L., Rosai, J., & Ladanyi, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1028 · Cited by 301
Microsatellites as EWS/FLI response elements in Ewing's sarcoma
Gangwal, K., Sankar, S., Hollenhorst, P. C., Kinsey, M., Haroldsen, S. C., Shah, A. A., Boucher, K. M., Watkins, W. S., Jorde, L. B., Graves, B. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801073105 · Cited by 297
Self-citationCause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Sadikovic, B., Al-Romaih, K., Squire, J., & Zielenska, M. (2008) · Current Genomics · doi:10.2174/138920208785699580 · Cited by 290
Lee, S. B., & Haber, D. A. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5131 · Cited by 288
Tanaka, K., Iwakuma, T., Harimaya, K., Sato, H., & Iwamoto, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119152 · Cited by 277
Lessnick, S. L., Dacwag, C. S., & Golub, T. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00056-9 · Cited by 264
Self-citationZinszner, H., Albalat, R., & Ron, D. (1994) · Genes & Development · doi:10.1101/gad.8.21.2513 · Cited by 264
Brown, L. A., Rodaway, A. R. F., Schilling, T. F., Jowett, T., Ingham, P. W., Patient, R. K., & Sharrocks, A. D. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00256-7 · Cited by 260
Promiscuous partnerships in Ewing's sarcoma
Sankar, S., & Lessnick, S. L. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.008 · Cited by 258
Self-citationThe Insulin-like Growth Factor-I Receptor Is Required for EWS/FLI-1 Transformation of Fibroblasts
Toretsky, J. A., Kalebic, T., Blakesley, V., LeRoith, D., & Helman, L. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30822 · Cited by 250
Male sterility and enhanced radiation sensitivity in TLS-/- mice
Kuroda, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.453 · Cited by 244
Ludwig, J. A. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328303ba1d · Cited by 240
Ewing’s sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities
Burchill, S. A. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.2.96 · Cited by 228
Biochemical Properties and Biological Functions of FET Proteins
Schwartz, J. C., Cech, T. R., & Parker, R. R. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034325 · Cited by 227
Classification and Subtype Prediction of Adult Soft Tissue Sarcoma by Functional Genomics
Segal, N. H., Pavlidis, P., Antonescu, C. R., Maki, R. G., Noble, W. S., DeSantis, D., Woodruff, J. M., Lewis, J. J., Brennan, M. F., Houghton, A. N., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63696-6 · Cited by 224
Jimenez, R. E., Folpe, A. L., Lapham, R. L., Ro, J. Y., O'Shea, P. A., Weiss, S. W., & Amin, M. B. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200203000-00005 · Cited by 219
NR0B1 Is Required for the Oncogenic Phenotype Mediated by EWS/FLI in Ewing's Sarcoma
Kinsey, M., Smith, R., & Lessnick, S. L. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0090 · Cited by 214
Self-citationUpdates on the cytogenetics and molecular genetics of bone and soft tissue tumors
Sandberg, A. A., & Bridge, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00002-5 · Cited by 214
Jousset, C., Carron, C., Boureux, A., Quang, C. T., Oury, C., Dusanter‐Fourt, I., Charon, M., Levin, J., Bernard, O., & Ghysdael, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.69 · Cited by 207
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
Okamoto, Y., Ozaki, T., Miyazaki, K., Aoyama, M., Miyazaki, M., & Nakagawara, A. (2003) · PubMed · Cited by 204
TLS, EWS and TAF15: a model for transcriptional integration of gene expression
Law, W. J. (2006) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/ell015 · Cited by 200
Ewing Sarcoma Family of Tumors
Khoury, J. D. (2005) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000175114.55541.52 · Cited by 195
Recent advances in the molecular pathogenesis of Ewing's sarcoma
Toomey, E. C., Schiffman, J. D., & Lessnick, S. L. (2010) · Oncogene · doi:10.1038/onc.2010.205 · Cited by 191
Self-citationEWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar, H., Aryee, D. N. T., Jug, G., Henöckl, C., SCHEMPER, M., Delattre, O., Thomas, G. D., & Gadner, H. (1996) · PubMed · Cited by 190
Molecular Pathogenesis of Ewing Sarcoma: New Therapeutic and Transcriptional Targets
Lessnick, S. L., & Ladanyi, M. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130237 · Cited by 190
Self-citationIdentification of an RNA Binding Specificity for the Potential Splicing Factor TLS
Lerga, A., Hallier, M., Delva, L., Orvain, C., Gallais, I., Marie, J., & Moreau-Gachelin, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008304200 · Cited by 189
The biology of DHX9 and its potential as a therapeutic target
Lee, T., & Pelletier, J. (2106) · Oncotarget · doi:10.18632/oncotarget.8446 · Cited by 188
Ets transcription factors and human disease
Dittmer, J., & Nordheim, A. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00039-5 · Cited by 185
Chromosomal translocations in cancer
Nambiar, M., Kari, V., & Raghavan, S. C. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.07.005 · Cited by 180
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
Lee, S. B., Kolquist, K. A., Nichols, K., Englert, C., Maheswaran, S., Ladanyi, M., Gerald, W. L., & Haber, D. A. (1997) · Nature Genetics · doi:10.1038/ng1197-309 · Cited by 180
Human Genome and Diseases:¶Double-strand breaks and translocations in cancer
Elliott, B., & Jasin, M. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8429-3 · Cited by 177
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors
Sandberg, A. A., & Bridge, J. A. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00462-9 · Cited by 176
Rocchi, A., Manara, M. C., Sciandra, M., Zambelli, D., Nardi, F., Nicoletti, G., Garofalo, C., Meschini, S., Astolfi, A., Colombo, M. P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36667 · Cited by 175
Self-citationEWS–ETS oncoproteins: The linchpins of Ewing tumors
Janknecht, R. (2005) · Gene · doi:10.1016/j.gene.2005.08.007 · Cited by 173
Sankar, S., Theisen, E. R., Bearss, J., Mulvihill, T., Hoffman, L. M., Sorna, V., Beckerle, M. C., Sharma, S., & Lessnick, S. L. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0072 · Cited by 173
Self-citationDauphinot, L., De Oliveira, C., Melot, T., Sevenet, N., Thomas, V., Weissman, B. E., & Delattre, O. (2001) · Oncogene · doi:10.1038/sj.onc.1204437 · Cited by 172
EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic
May, W. A., Arvand, A., Thompson, A. D., Braun, B. S., Wright, M. M., & Denny, C. T. (1997) · Nature Genetics · doi:10.1038/ng1297-495 · Cited by 171
Self-citationOncogenic Partnerships: EWS-FLI1 Protein Interactions Initiate Key Pathways of Ewing's Sarcoma
Erkizan, H. V., Uversky, V. N., & Toretsky, J. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2261 · Cited by 169
Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
Sankar, S., Bell, R., Stephens, B., Zhuo, R., Sharma, S., Bearss, D. J., & Lessnick, S. L. (2013) · Oncogene · doi:10.1038/onc.2012.525 · Cited by 167
Self-citationUpdates on cytogenetics and molecular genetics of bone and soft tissue tumors:
Sandberg, A. A., & Bridge, J. A. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00295-8 · Cited by 165
Awad, O., Yustein, J. T., Shah, P., Gul, N., Katuri, V., O'Neill, A., Kong, Y., Brown, M. L., Toretsky, J. A., & Loeb, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013943 · Cited by 163
The diversity of soft tissue tumours with EWSR 1 gene rearrangements: a review
Fisher, C. (2014) · Histopathology · doi:10.1111/his.12269 · Cited by 163
Braun, B. S., Frieden, R., Lessnick, S. L., May, W. A., & Denny, C. T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4623 · Cited by 162
Self-citationThe ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells
Wai, D. H., Knezevich, S. R., Lucas, T., Jansen, B., Kay, R. J., & Sorensen, P. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203396 · Cited by 162
Giovannini, M., Biegel, J. A., Serra, M., Wang, J. Y., Wei, Y. H., Nycum, L., Emanuel, B. S., & Evans, G. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117360 · Cited by 162
Primary Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney
Muradyan, A. G., Vorobyev, N. V., Fedenko, A. A., Volchenko, N. N., Goeva, N. S., & Izmailov, A. A. (2021) · Onkologiya. Zhurnal imeni P.A.Gertsena · doi:10.17116/onkolog20211005150 · Cited by 161
Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions
Wang, L., Bhargava, R., Zheng, T., Wexler, L., Collins, M. H., Roulston, D., & Ladanyi, M. (2007) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.070053 · Cited by 161
Fused in sarcoma (FUS): An oncogene goes awry in neurodegeneration
Dormann, D., & Haass, C. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.03.006 · Cited by 160
A review of soft-tissue sarcomas: translation of biological advances into treatment measures
Hoang, N. T., Acevedo, L. A., Mann, M. J., & Tolani, B. (2018) · Cancer Management and Research · doi:10.2147/cmar.s159641 · Cited by 159
Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development
Li, K., Watford, W. T., Li, C., Parmelee, A., Bryant, M., Deng, C., O’Shea, J. J., & Lee, S. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31222 · Cited by 157
Identification of p21 as a Direct Target of EWS-Fli1 Oncogenic Fusion Protein
Nakatani, F., Tanaka, K., Sakimura, R., Matsumoto, Y., Matsunobu, T., Li, X., Hanada, M., Okada, T., & Iwamoto, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211470200 · Cited by 155
The role of Fli-1 in normal cell function and malignant transformation
Truong, A. H. L., & Ben‐David, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1204042 · Cited by 155
Owen, L. A., Kowalewski, A. A., & Lessnick, S. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001965 · Cited by 155
Self-citationYang, L., Chansky, H. A., & Hickstein, D. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005739200 · Cited by 154
Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells
Hollenhorst, P. C., Ferris, M. W., Hull, M. A., Chae, H., Kim, S., & Graves, B. J. (2011) · Genes & Development · doi:10.1101/gad.17546311 · Cited by 154
A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature
Hancock, J. D., & Lessnick, S. L. (2008) · Cell Cycle · doi:10.4161/cc.7.2.5229 · Cited by 152
Self-citationThe EWS–WT1 gene fusion in desmoplastic small round cell tumor
Gerald, W. L., & Haber, D. A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.01.005 · Cited by 145
The Ewing's sarcoma gene product functions as a transcriptional activator.
Rossow, K. L., & Janknecht, R. (2001) · PubMed · Cited by 144
Stegmaier, K., Wong, J. S., Ross, K. N., Chow, K. T., Peck, D., Wright, R. D., Lessnick, S. L., Kung, A. L., & Golub, T. R. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040122 · Cited by 143
Self-citationMartins, A. S., Mackintosh, C., Martín, D. H., Campos, M., Hernández, T., Ordóñez, J. L., & de Álava, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1778 · Cited by 142
PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors
Zwerner, J. P., & May, W. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204133 · Cited by 141
Self-citationFuchs, B., Inwards, C. Y., & Janknecht, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0038 · Cited by 139
Kang, J., Lim, L., Lu, Y., & Song, J. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000327 · Cited by 139
Erratum: Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
Sankar, S., Bell, R. N., Stephens, B. J., Zhuo, R., Sharma, S., Bearss, D. J., & Lessnick, S. L. (2016) · Oncogene · doi:10.1038/onc.2016.142 · Cited by 139
Self-citationSancéau, J., Hiscott, J. B., Delattre, O., & Wietzerbin, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203670 · Cited by 135
The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.
Mao, X., Miesfeldt, S., Yang, H., Leiden, J. M., & Thompson, C. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32437-7 · Cited by 132
CDK12: an emerging therapeutic target for cancer
Lui, G. Y. L., Grandori, C., & Kemp, C. J. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205356 · Cited by 131
Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells
Thompson, A. D., Teitell, M. A., Arvand, A., & Denny, C. T. (1999) · Oncogene · doi:10.1038/sj.onc.1202928 · Cited by 130
Self-citationEwing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells.
Torchia, E. C., Jaishankar, S., & Baker, S. J. (2003) · PubMed · Cited by 130
The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case.
Cazzaniga, G., Daniotti, M., Tosi, S., Giudici, G., Aloisi, A., Pogliani, E., Kearney, L., & Biondi, A. (2001) · PubMed · Cited by 129
Möller, E., Stenman, G., Mandahl, N., Hamberg, H., Mölne, L., van den Oord, J., Brosjö, O., Mertens, F., & Panagopoulos, I. (2008) · The Journal of Pathology · doi:10.1002/path.2327 · Cited by 129
The EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma
Chaturvedi, A. P., Hoffman, L. M., Welm, A. L., Lessnick, S. L., & Beckerle, M. C. (2012) · Genes & Cancer · doi:10.1177/1947601912457024 · Cited by 127
Self-citationZhang, D., Paley, A. J., & Childs, G. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18086 · Cited by 126
Bennicelli, J. L., Advani, S., Schäfer, B. W., & Barr, F. G. (1999) · Oncogene · doi:10.1038/sj.onc.1202812 · Cited by 126
Thorner, P. S., Squire, J. A., Chilton‐MacNeill, S., Marrano, P. M., Bayani, J., Malkin, D. M., Greenberg, M., Lorenzana, A., & Zieleńska, M. (1996) · Europe PMC (PubMed Central) · Cited by 125
Analysis of the ERK-Stimulated ETS Transcription Factor ER81
Janknecht, R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1550 · Cited by 124
Identification of Target Genes of the p16INK4A-pRB-E2F Pathway
Vernell, R., Helin, K., & Müller, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304930200 · Cited by 123
Sjögren, H., Wedell, B., Meis‐Kindblom, J. M., Kindblom, L., Stenman, G., & Kindblom, J. M. (2000) · PubMed · Cited by 123
Nishimori, H., Sasaki, Y., Yoshida, K., Irifune, H., Zembutsu, H., Tanaka, T., Aoyama, T., Hosaka, T., Kawaguchi, S., Wada, T., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1206025 · Cited by 122
EWS/FLI Alters 5′-Splice Site Selection
Knoop, L. L., & Baker, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008950200 · Cited by 120
Sorensen, P. H. B., Shimada, H., Liu, X. F., Lim, J. F., Thomas, G. D., & Triche, T. J. (1995) · PubMed · Cited by 119
Identification of Ewing’s sarcoma protein as a G‐quadruplex DNA‐ and RNA‐binding protein
Takahama, K., Kino, K., Arai, S., Kurokawa, R., & Oyoshi, T. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08020.x · Cited by 118
Metadata
- Authors
- May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T.
- Affiliations
- University of California, Los Angeles (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1993-12
- Volume
- 13
- Issue
- 12
- Pages
- 7393-7398
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC364810
- OpenAlex
- W1789215739
- Cited by
- 497
- References
- 33
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 13 · 2022: 8 · 2021: 12 · 2020: 14 · 2019: 14 · 2018: 10 · 2017: 8 · 2016: 16 · 2015: 15 · 2014: 22 · 2013: 25 · 2012: 20
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- National Institute of General Medical Sciences (T32GM008042)
- National Institute of Allergy and Infectious Diseases (T32AI007126)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- FLI1, Ewing sarcoma, primitive neuroectodermal tumor, 22 translocation, transcriptional activator, GAL4 DNA-binding domain, nuclear localization
- MeSH terms
- Animals, Base Sequence, Binding Sites, Cell Line, Cell Nucleus, Cell Transformation, Neoplastic, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, DNA-Binding Proteins, DNA, Neoplasm, HeLa Cells, Humans, Molecular Sequence Data, Oncogenes, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Sarcoma, Ewing, Translocation, Genetic, Trans-Activators, 3T3 Cells, Mice, Proto-Oncogene Protein c-fli-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.